Clinical Trial Update: Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory Study

View source ↗

Summary

This exploratory clinical trial evaluates the effects of RV4660C CY0203 on clinical, biometric and biological parameters in adults with mild to moderate atopic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• RV4660C CY0203

Snippet

Sponsor: Pierre Fabre Dermo Cosmetique | Conditions: Mild to Moderate Atopic Dermatitis | Status: COMPLETED